Navigation Links
First-Ever Over-the-Counter Dual Action Iron Supplement Launched at the American Dietetic Association Conference in Chicago; Bifera to be Available in Select Stores in Early 2009
Date:10/27/2008

New, dual action iron supplement pill with virtually no gastrointestinal side effects for people who need the energy and nutritional benefits from

iron to be available without prescription

CHICAGO, Oct. 27 /PRNewswire/ -- Announced today at the American Dietetic Association, Bifera (http://www.alavenpharm.com), an over-the-counter iron supplement that offers both heme (protein-based iron) and non-heme iron (plant-based iron) will be available in stores in early 2009. Unlike other iron supplements, Bifera provides two types of iron in one small pill for maximum absorption with virtually no gastrointestinal side effects.

Bifera is similar to Alaven's current prescription prenatal supplement PreferaOB, which contains both heme and non-heme iron.

"Bifera -- unlike all other over-the-counter iron supplements that only include non-heme iron -- is steak and potato in pill form for people who need the energy and nutritional benefits provided by both heme and non-heme iron," said Autumn Akin, Bifera product manager.

According to Akin, heme is the key that unlocks the efficiency of non-heme iron. Recent studies show the heme iron found in Bifera offers 23 times greater absorption than other iron supplements.

"When patients are deficient in iron, their organs aren't performing at maximum capacity and they experience a decrease in energy," said Akin. "Similar to a hybrid car, Bifera is small, efficient and produces energy quickly without unwanted side effects, like nausea and constipation."

"Bifera can be taken on an empty stomach, with other multi-vitamin supplements and, unlike other iron supplements currently on the market, Bifera can be taken in conjunction with acid reduction medications," said Akin.

Bifera is recommended for adults already taking supplemental iron, women of childbearing age, pregnant women, anemics, and men and women who simply
'/>"/>

SOURCE Bifera
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. First-Ever List of the 5,000 Fastest-Growing Businesses Reports Total Revenue of $194.5 Billion
2. Fred Hutchinson Cancer Research Center Announces the First-Ever Expedition to an Unclimbed Mountain in the Name of Cancer Research
3. Y-ME Illinois Hosts the First-Ever BIG Night Out - Indulgence for a Cause
4. TriWest and Alaska VA Hosted First-Ever PTSD State-Wide Seminars to Reach Rural Health Care Providers
5. Oregon Scientific to Sponsor First-Ever Rock Concert on Mount Everest
6. AACR to host first-ever meeting on the science of cancer health disparities
7. E.D.G.E. in Leadership Study Delivers First-Ever Data on Executive Women in Pharmaceutical and Biotech Industries
8. First-Ever Collaborative Summit on Breast Cancer Research Targets New Partnerships and Collaborative Solutions
9. URAC Names Medco as a Finalist in First-ever Best Practices in Consumer Empowerment and Protection Awards
10. First-Ever Saddleback AIDS Youth Summit Addresses a Future Without HIV On World Aids Day:
11. URAC Names Sensei for Weight Loss as a Finalist in First-Ever Best Practices in Consumer Empowerment and Protection Awards
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... ... 2015 , ... RxNT , an innovative software solutions ... cloud-based mobile ePrescribing application. The release of this enhanced iPhone app marks the ... in health technology, RxNT was one of the first to build an ePrescribing ...
(Date:9/2/2015)... Schwerzenbach, Switzerland (PRWEB) , ... September 02, 2015 ... ... quality control of incoming goods, intermediate or final products. Automating sample handling makes ... and automated sample handling, showing each step of the automated workflow and the ...
(Date:9/2/2015)... ... September 02, 2015 , ... A UPMC ... has earned international recognition as a premier center for treatment of and research ... catastrophic internal bleeding and stroke. , Cure HHT, previously known as The ...
(Date:9/2/2015)... ... September 02, 2015 , ... Ericson is a noted speaker and educator ... and Associate Director of Education for the Association for Clinical Documentation Improvement Specialists (ACDIS) ... CDI Boot Camps. She serves as a CDI subject matter expert for a variety ...
(Date:9/2/2015)... ... September 02, 2015 , ... The 2015 China ... international investment and business conference will be hosted at five star Beijing Kunlun ... full-weekend networking conference will feature leading EB-5 industry professionals and Chinese private equity ...
Breaking Medicine News(10 mins):Health News:RxNT Releases Enhanced ePrescribing iPhone App to Improve Prescriber Usability 2Health News:New Video from METTLER TOLEDO Shows the Advantages of Sample Handling Automation in Density Determination 2Health News:New Video from METTLER TOLEDO Shows the Advantages of Sample Handling Automation in Density Determination 3Health News:UPMC-University of Pittsburgh Named Center of Excellence for Rare Disorder 2Health News:UPMC-University of Pittsburgh Named Center of Excellence for Rare Disorder 3Health News:UPMC-University of Pittsburgh Named Center of Excellence for Rare Disorder 4Health News:ezDI Names Noted CDI Educator Cheryl Ericson as Company’s Clinical Documentation Manager 2Health News:ezDI Names Noted CDI Educator Cheryl Ericson as Company’s Clinical Documentation Manager 3Health News:ezDI Names Noted CDI Educator Cheryl Ericson as Company’s Clinical Documentation Manager 4Health News:The 2015 China Overseas Investment and Entrepreneurship Summit (COIES) Announced 2
... Inc. (Nasdaq: MYL ) today announced that ... its delisting offer for the publicly held shares of ... ingredient manufacturer in which Mylan acquired a controlling interest ... rupees per share, which was established by the reverse ...
... George Tiller is an abhorrent act of violence, and his ... moment. Federal law enforcement is coordinating with local law ... and I have directed the United States Marshals Service to ... nation. The Department of Justice will work to bring ...
... (May 31, 2009)Fox Chase Cancer Center investigators report that ... metastatic kidney cancer in a phase I trial. Early ... may be active in patients with rare forms of ... to other targeted therapies. , Elizabeth Plimack, M.D., M.S., ...
... MAY 31, 2009 The American Society for ... of endoscopy during the fifth annual ASGE Crystal Awards on ... this year,s event will begin at 6:30 p.m. at Navy ... Disease Week (DDW), the ASGE Crystal Awards symbolize the finest ...
... to start San Francisco-to-Los Angeles ride May 31SAN FRANCISCO ... bicyclists from 41 states and 14 nations will stream ... to Los Angeles as participants in the colorful and ... trek is expected to raise $10.5 million to support ...
... PITTSBURGH, May 30 Patients undergoing treatment for advanced ... addition of gefinitib to chemotherapy, according to a study ... by Ethan Argiris, M.D., associate professor of medicine, University ... Head and Neck Cancer Program of the University of ...
Cached Medicine News:Health News:Mylan Announces Successful Matrix Delisting Offer 2Health News:2-drug combination appears safe and active in metastatic kidney cancer 2Health News:ASGE and ASGE Foundation hold Crystal Awards Dinner as part of Digestive Disease Week 2Health News:ASGE and ASGE Foundation hold Crystal Awards Dinner as part of Digestive Disease Week 3Health News:ASGE and ASGE Foundation hold Crystal Awards Dinner as part of Digestive Disease Week 4Health News:ASGE and ASGE Foundation hold Crystal Awards Dinner as part of Digestive Disease Week 5Health News:ASGE and ASGE Foundation hold Crystal Awards Dinner as part of Digestive Disease Week 6Health News:ASGE and ASGE Foundation hold Crystal Awards Dinner as part of Digestive Disease Week 7Health News:AIDS/LifeCycle 8 to Raise $10.5 Million to Fight AIDS 2Health News:AIDS/LifeCycle 8 to Raise $10.5 Million to Fight AIDS 3Health News:AIDS/LifeCycle 8 to Raise $10.5 Million to Fight AIDS 4Health News:New treatment combination proves safe for head and neck cancer patients 2
(Date:9/2/2015)... STAAR Surgical Company (NASDAQ: STAA ), a leading developer, ... the eye, today announced that its Board of Directors has ... Mr. Wall was formerly the General Counsel ... firm, for more than nine years. Mr. Wall is currently ... the Corporate Governance Committee and member of the Audit Committee, ...
(Date:9/2/2015)... and Markets ( http://www.researchandmarkets.com/research/l8z67c/pharmaceutical ) has announced the addition of ... November 26-27, 2015)" conference to their offering. ... key areas of pharmaceutical regulatory affairs in China ... Macau and Taiwan and ... gaining and maintaining a successful Marketing Authorisation in the region ...
(Date:9/2/2015)... OAKS, Calif. , Sept. 2, 2015 /PRNewswire/ ... the submission of a Marketing Authorization Application (MAA) ... centralized procedure for etelcalcetide (formerly AMG 416) for ... patients with chronic kidney disease (CKD) on hemodialysis ... calcimimetic agent that can be administered intravenously. ...
Breaking Medicine Technology:William P. Wall Appointed to STAAR Surgical Board of Directors 2Pharmaceutical Regulatory Affairs in China Seminar: Basel, Switzerland - November 26-27, 2015 2Amgen Submits Marketing Authorization Application For Novel Intravenous Calcimimetic Etelcalcetide (AMG 416) To The European Medicines Agency 2Amgen Submits Marketing Authorization Application For Novel Intravenous Calcimimetic Etelcalcetide (AMG 416) To The European Medicines Agency 3Amgen Submits Marketing Authorization Application For Novel Intravenous Calcimimetic Etelcalcetide (AMG 416) To The European Medicines Agency 4Amgen Submits Marketing Authorization Application For Novel Intravenous Calcimimetic Etelcalcetide (AMG 416) To The European Medicines Agency 5Amgen Submits Marketing Authorization Application For Novel Intravenous Calcimimetic Etelcalcetide (AMG 416) To The European Medicines Agency 6Amgen Submits Marketing Authorization Application For Novel Intravenous Calcimimetic Etelcalcetide (AMG 416) To The European Medicines Agency 7
... loss of Arf gene in presence of BCR-ABL ... of the bone,marrow, helping cells develop immunity to ... 29 Results of a study,by investigators at ... why the drug imatinib (Gleevec(TM)), which has revolutionized,the ...
... from Roche-, MONTVALE, N.J., Aug. 29 ... the dosing of the,first subject in the single ... program of R4996/MEM 63908, a partial agonist of ... could be beneficial in,the treatment of Alzheimer,s disease ...
Cached Medicine Technology:St. Jude Discovers Factors That Accelerate Resistance to Gleevec(TM) Targeted Therapy in Lymphoblastic Leukemia 2Memory Pharmaceuticals Commences Phase 1 Clinical Program for R4996/MEM 63908 2Memory Pharmaceuticals Commences Phase 1 Clinical Program for R4996/MEM 63908 3
Use the Mo Bio Vortex adapter to process multiple samples at the same time. The adapter holds tubes horizontally to increase cell lysis and mixing efficiency. Ideal for bead beating procedures....
... Bio Vortex Adapter in conjunction with the Vortex ... Using the Mo Bio Vortex Adapter is an ... Prep machines which offer the same technology. ... tubes at one time and will fit any ...
... V-500 with Vacuum Controller V-800 and water-cooled secondary ... Compact Housing Model V-500 ... to handle most vacuum applications. Applications ... two rotary evaporators Laboratory vacuum source ...
... V-500 with Vacuum Controller V-800 and water-cooled secondary ... Model V-500 is a powerful ... vacuum applications. Applications Ideally suited ... Laboratory vacuum source for instruments including ...
Medicine Products: